Establishing criteria for pediatric epilepsy surgery center levels of care: Report from the ILAE Pediatric Epilepsy Surgery Task Force
Gaillard, William D.; Jette, Nathalie; Arnold, Susan T.; Arzimanoglou, Alexis; Braun, Kees P.J.; Cukiert, Arthur; Dick, Alexander; Harvey, A. Simon; Jacobs, Julia; Rydenhag, Bertil; Udani, Vrajesh; Wilmshurst, Jo M.; Cross, J. Helen; Jayakar, Prasanna; Task Force for Pediatric Epilepsy Surgery, Commission for Pediatrics, and the Surgical Commission of the International League Against Epilepsy
(2020) Epilepsia, volume 61, issue 12, pp. 2629 - 2642
(Article)
Abstract
Presurgical evaluation and surgery in the pediatric age group are unique in challenges related to caring for the very young, range of etiologies, choice of appropriate investigations, and surgical procedures. Accepted standards that define the criteria for levels of presurgical evaluation and epilepsy surgery care do not exist. Through a
... read more
modified Delphi process involving 61 centers with experience in pediatric epilepsy surgery across 20 countries, including low-middle- to high-income countries, we established consensus for two levels of care. Levels were based on age, etiology, complexity of presurgical evaluation, and surgical procedure. Competencies were assigned to the levels of care relating to personnel, technology, and facilities. Criteria were established when consensus was reached (≥75% agreement). Level 1 care consists of children age 9 years and older, with discrete lesions including hippocampal sclerosis, undergoing lobectomy or lesionectomy, preferably on the cerebral convexity and not close to eloquent cortex, by a team including a pediatric epileptologist, pediatric neurosurgeon, and pediatric neuroradiologist with access to video-electroencephalography and 1.5-T magnetic resonance imaging (MRI). Level 2 care, also encompassing Level 1 care, occurs across the age span and range of etiologies (including tuberous sclerosis complex, Sturge-Weber syndrome, hypothalamic hamartoma) associated with MRI lesions that may be ill-defined, multilobar, hemispheric, or multifocal, and includes children with normal MRI or foci in/abutting eloquent cortex. Available Level 2 technologies includes 3-T MRI, other advanced magnetic resonance technology including functional MRI and diffusion tensor imaging (tractography), positron emission tomography and/or single photon emission computed tomography, source localization with electroencephalography or magnetoencephalography, and the ability to perform intra- or extraoperative invasive monitoring and functional mapping, by a large multidisciplinary team with pediatric expertise in epilepsy, neurophysiology, neuroradiology, epilepsy neurosurgery, neuropsychology, anesthesia, neurocritical care, psychiatry, and nursing. Levels of care will improve safety and outcomes for pediatric epilepsy surgery and provide standards for personnel and technology to achieve these levels.
show less
Download/Full Text
The full text of this publication is not available.
Keywords: care, children, epilepsy, surgery, Neurology, Clinical Neurology
ISSN: 1528-1167
Publisher: Wiley-Blackwell
Note: Funding Information: ILAE Statement: This report was written by a team selected by the ILAE and was approved for publication by the ILAE. Opinions expressed by the authors, however, do not necessarily represent official policy or the position of the ILAE. Other Members Who Participated in the Study: Mario A. Alonso-Vanegas, National Institute of Neurology and Neurosurgery; Carmen Barba, University of Florence; Lixin Cai, Pediatric Epilepsy Center, Peking University First Hospital; Sarat Chandra, All India Institute of Medical Sciences; Hsin-Hung Chen, Taipei Veteran's General Hospital; Mathilde Chipaux, Rothschild Foundation Hospital; Chun Kee Chung R., Seoul National University; Mary Connolly, University of British Columbia; Luca Del Palma, Sapienza University; Petia Dimova, St Ivan Rilski University Hospital, Sofia, Bulgaria; Jason Doescher, Minnesota Epilepsy Group; Elizabeth Donner, Hospital for Sick Children, University of Toronto; Deepak Gill, Children's Hospital at Westmead; Ajay Gupta, Cleveland Clinic; Michael Handler, Colorado Children's Hospital; Adam Hartman, Johns Hopkins Hospital; J. (Hans) Holthausen, Schon Kliniken; Sergiusz Józwiak, Medical University of Warsaw; Philippe Kahane, Grenoble-Alpes University and Hospital; Lakshminarayanan Kannan, Gleneagles Global Hospitals; Kensuke Kawai, Jichi Medical University; Jack Kerrigan, Phoenix Children's Hospital; Sudha Kessler, Children's Hospital of Philadelphia; Pavel Krsek, Motol University Hospital, Prague; Jianxiang Liao, Shenzhen Children's Hospital; Mark Libenson, Boston Children's Hospital; Xian Lun Zhu, Prince of Wales Hospital, University of Hong Kong; Helio Machado, University of Ribeirao Preto; Wirginia Maixner, Royal Children's Hospital; Stephen Malone, University of Queensland; Timothy Martland, Central Manchester University Hospitals; Gary Mathern, University of California, Los Angeles; Ailsa McLellan, Royal Hospital for Sick Children; Liisa Metsahonkala, Helsinki University Hospital; Doug Nordli, University of Chicago; Jeff Ojeman, Seattle Children's Hospital, University of Washington; Chima Oluigbo, Children's National Medical Center; Ashok Pillai, Amrita Institute of Medical Sciences; Tilman Polster, Mara Hospital, Bethel Epilepsy Center; Hugo Pomata, Comprehensive Epilepsy Center, Institute for Neurological Research; Vinayan K. Puthenveettil, Amrita Institute of Medical Sciences; Victoria San Antonio, Barcelona Children's Hospital; Didier Scavarda, Aix-Marseille University/La Timone Hospital in Marseille; Benedict M. Selladurai, Hospital Universiti Kebangsaan Malaysia; Shlomo Shinnar, Montefiore Hospital, Einstein University; Piradee Suwanpakdee, Phramongkutklao Hospital; Laura Tassi, Claudio Munari Epilepsy Surgery Center, Ospedale Niguada; Agnes Trebuchon, Aix-Marseille University/La Timone Hospital in Marseille; Yi Wang, Children's Hospital of Fudan University; Howard Weiner, Texas Children's Hospital, Baylor University; Jim Whelass, Memphis Children's Hospital; Elaine Wirrell, Mayo Clinic. We thank Rachel Reed for assistance in preparing the manuscript. Publisher Copyright: © 2020 International League Against Epilepsy
(Peer reviewed)